| 15.50 |  -0.12 / -0.77% |
Data as of 4:00pm ET | Day’s Change |
| 15.50 |  0.00 / 0.00% |
Volume: 6.6K |
| Previous close | 15.62 |
| Today’s open | 15.73 |
| Day’s range | 15.38 - 16.96 |
| Volume | 533,727 |
| Average volume (3 months) | 772,145 |
| Market cap | $291.2M |
| Dividend yield | -- |
| Earnings growth (last year) | -13.46% |
| Earnings growth (this year) | -13.35% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 11.64 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNSSSunesis Pharmaceutic... | -0.11 | -1.96% |
| NAVBNavidea Biopharmaceu... | -0.10 | -4.00% |
| CNDOCoronado Biosciences... | -0.45 | -4.58% |
| RGENRepligen Corp | -0.38 | -4.41% |
| Next reporting date | August 19, 2013 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$18.2M |
| Net profit margin | -- |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Joseph S. Podolski |
Secretary, Chief Financial & Accounting Officer Katherine A. Anderson, CPA |
Corporate headquarters The Woodlands, Texas |
.
